News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
With an immune system designed to destroy invading organisms, patients receiving organ transplants often run the risk of becoming their own worst enemies.
But by transferring some of the donor’s bone marrow along with the organs, two Medical School researchers have found a way to fool immune cells into accepting foreign tissue as well. Four of the five study’s subjects received successful transplants.
Researchers believe the new procedure, which begins with a partial destruction of the patient’s bone marrow using a drug, may decrease organ rejection. The bone marrow gives rise to immune cells that help the body identify invaders. If the foreign marrow produces foreign cells, the study’s authors hypothesized that the body will recognize the transplant as one of its own.
But the researchers, David H. Sachs and A. Benedict Cosimi, are looking beyond mere human transplants. They’ve already filed a patent for transplants from animals to humans.
For recent research, faculty profiles, and a look at the issues facing Harvard scientists, check out The Crimson's science page.
Want to keep up with breaking news? Subscribe to our email newsletter.